 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 661 - 670 of 2187:
FDA criticized after study finds drug-related deaths up
The number of serious injuries and deaths from drugs reported to the U.S. Food and Drug Administration more than doubled between 1998 and 2005, accord...
FDA Criticized for Slow Approvals but Allows 21 New Drugs This Year
No doubt, 2008 has been a rough year just about everywhere, with slings and arrows targeting everybody from an ambitious plumber to the president. So...
FDA criticized over its response to salmonella outbreak
Turf struggles, bad communication and weak leadership undermined the federal response to a recent salmonella outbreak that cost the tomato industry hu...
FDA Criticizes Seroquel Marketing
U.S. regulators are criticizing AstraZeneca PLC’s marketing strategies for its drug, Seroquel, said Reuters. Seroquel is one of a class of drugs know...
FDA damned if it does, damned if it doesn't
The FDA just can't win. After years of public ridicule and congressional scrutiny, the Food and Drug Administration is taking a tougher stance against...
FDA Deadlines May Affect Drug Safety
According to a study published in the New England Journal of Medicine deadlines for response to new drug applications may be causing the agency to mak...
FDA Decides Against Warnings on Epilepsy Medication Suicide Risk
The FDA has decided against placing new warning labels on anti-seizure medications used to treat epilepsy, in spite of recent findings that those drug...
FDA Decisions On Drug Approval Could Start Slipping
Ever since the drug industry started funding the FDA’s review of drugs for approval, the agency’s been pretty diligent about responding to applicants ...
FDA Declares Bisphenol-A Plastics Chemical to be Safe, Relying on Industry-Funded Studies
Testifying before the Senate, FDA Associate Commissioner for Science Norris Alderson insisted that products made with bisphenol A (BPA) are safe, even...
FDA Declines Approval For Lilly Antipsychotic
The U.S. Food and Drug Administration has declined to approve Eli Lilly & Co.'s (LLY) application to market a long-acting formulation of its antipsyc... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |